Yogasleep/Ipsos Sleep Survey 2021 Announcement

Two in Five (39%) Americans Report Worse Sleep Quality in the Past Year - 30% are Hopeful That Better Sleep is Coming
The Yogasleep/IPSOS Sleep Reset Survey found that only a third (35%) of men reported getting worse sleep versus 44% of women. 

WILMINGTON, N.C., March 15, 2021 – As Americans mark one year of the pandemic and look forward to signs of relief, a new Yogasleep/IPSOS survey asked about the past year’s sleep habits and their thoughts on a sleep reset in the coming months.

The poll found that 39% of Americans say their sleep has gotten somewhat/much worse in the past year – compared to 11% who found their sleep actually improved over the year – leaving half reporting their sleep quality staying roughly the same. Women reported worse sleep (44%) as compared to 35% of men, and 4% of men reported actually getting much better sleep. Looking ahead there is optimism for sleep quality to improve, with 30% of Americans expecting better sleep versus a mere 9% who believe their sleep will worsen. The vast majority of Americans (61%) don’t believe their sleep will change in the coming year. Women are more hopeful for better sleep (31%) than men (28%).

For Americans who are unvaccinated, or not fully vaccinated for COVID, 37% believe they will sleep better from the relief, but for those who are already fully vaccinated, a majority (51%) report the relief does help them get better sleep.

Full survey methodology is below. This poll was conducted on March 2nd and 3rd with a sample of 1005 adults. Media will be provided the raw tabulated data upon request.

More survey details:

 Households with children:

  • In the past year has the quality of your sleep changed?

                Households with Children:

  • 18% It has gotten better or much better
  • 41% It has gotten worse or much worse
  • 41% Stayed about the same
  • Steps taken to improve sleep – Households with Children:
    • 30% reduced screen time – nearly double the general population (18%)
    • 20% purchased sleep products
    • 19% tried sleep tracking
  • 40% of Households with Children believe their sleep will improve over the coming year (versus 30% in the general population).
  • 59% of Households with Children have plans to improve their sleep in the coming 6 to 9 months, significantly higher than the full poll participants (45%).

Americas already fully vaccinated were asked if the relief of getting the shot improved their sleep and 51% said yes – however there were significant differences in various demographics:

  • 65% of men felt that relief versus only 29% of women
  • Three Quarters (75%) of adults under the age of 55 reported better sleep from relief versus only 33% of those 55 years or older.

 * * *

For more data and information, contact:

About Yogasleep (Marpac, LLC)

Marpac, LLC sells its quality sleep products under its flagship brand Yogasleep®. Based in Wilmington, N.C., it was founded in 1962 with the creation of the original white noise machine now called the Dohm®. Over the decades it has grown by providing quality sleep and privacy products while providing the highest levels of customer service. Yogasleep sound machines include the Dohm family of natural, fan-based white noise machines, electronic multi-sound machines for home and travel and commercial devices. Yogasleep has expanded its natural sleep products with direct-to-consumer mattress under the Yogabed® brand. Our products are sold on and wherever people shop for quality sleep products.

About Ipsos

Ipsos is the world’s third largest Insights and Analytics company, present in 90 markets and employing more than 18,000 people.

 Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. We serve more than 5000 clients across the world with 75 business solutions.

Founded in France in 1975, Ipsos is listed on the Euronext Paris since July 1st, 1999. The company is part of the SBF 120 and the Mid-60 index and is eligible for the Deferred Settlement Service (SRD).

 ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP

Public Poll Findings and Methodology

The sample for this study was randomly drawn from Ipsos’ online panel (see link for more info on “Access Panels and Recruitment”), partner online panel sources, and “river” sampling (see link for more info on the Ipsos “Ampario Overview” sample method) and does not rely on a population frame in the traditional sense. Ipsos uses fixed sample targets, unique to each study, in drawing a sample. After a sample has been obtained from the Ipsos panel, Ipsos calibrates respondent characteristics to be representative of the U.S. Population using standard procedures such as raking-ratio adjustments. The source of these population targets is U.S. Census 2018 American Community Survey data. The sample drawn for this study reflects fixed sample targets on demographics. Posthoc weights were made to the population characteristics on gender, age, race/ethnicity, region, and education.

Statistical margins of error are not applicable to online non-probability polls. All sample surveys and polls may be subject to other sources of error, including, but not limited to coverage error and measurement error. Where figures do not sum to 100, this is due to the effects of rounding. The precision of Ipsos online polls is measured using a credibility interval. In this case, the poll has a credibility interval of plus or minus 3.5 percentage points for all respondents. Ipsos calculates a design effect (DEFF) for each study based on the variation of the weights, following the formula of Kish (1965). This study had a credibility interval adjusted for design effect of the following (n=1,005, DEFF=1.5, adjusted Confidence Interval =  +/-5.0 percentage points for all respondents).


# # #